Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Efficacy and Safety of an Infant Formula Containing Synbiotics and Its Effects on the Incidence of Infectious Diseases in the Infant Gut : a Double-blind, Randomized, Controlled Interventional Study

NCT02221687 is registered in ClinicalTrials.gov with HiPP GmbH & Co. Vertrieb KG as lead sponsor.

NCT NCT02221687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02221687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Efficacy and Safety of an Infant Formula Containing Synbiotics and Its Effects on the Incidence of Infectious Diseases in the Infant Gut : a Double-blind, Randomized, Controlled Interventional Study
Lead sponsor
HiPP GmbH & Co. Vertrieb KG
Phase
Not applicable
Overall status
Terminated
Start date
August 31, 2014
Completion date
April 30, 2021
Enrollment
540 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

healthy term infants